Sanoculis
Manufacturing · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Tel Aviv, Tel Aviv, IsraelPhone Number
+972 35503432Website
www.sanoculis.comRevenue
<$5 MillionIndustry
About Sanoculis
Sanoculis Org Chart
Is Sanoculis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Sanoculis, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Sanoculis recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Sanoculis
Click to see if Sanoculis had a recent Job posting/layoffs
Check if Sanoculis has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Sanoculis launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Sanoculis is spiking on competitors!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Sanoculis has new funding data
Recommended Actions
Find VP level buyers at Sanoculis
Find 2 more new buyers
Company Profile Activity
Activity Insights
Sanoculis is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Sanoculis is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sanoculis.
Sanoculis Tech Stack
A closer look at the technologies used by Sanoculis
Sanoculis News & Media
Eckuity Joins Bausch + Lomb in an Equity Investment in Sanoculis
NEW YORK and TEL AVIV, Israel, Jan. 25, 2023 /PRNewswire/ -- Eckuity, a New York and London based venture capital investor has invested alongside Bausch + Lomb in Sanoculis, an Israeli ophthalmic medical device company, as part of the Series C round of funding. Sanoculis and Bausch + Lomb...Bausch + Lomb and Sanoculis Announce Strategic Agreements Designed to Address Unmet Needs in Glaucoma
Bausch + Lomb Has Made an Equity Investment in Sanoculis and Has Entered into an Exclusive European Distribution Agreement for MIMS® Minimally Invasive Surgical Procedure VAUGHAN, ON and TEL AVIV, Israel, July 28, 2022 /PRNewswire/ -- Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch +...
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sanoculis
Sanoculis Ltd. specializes in ophthalmic medical device technology, focusing on innovative, stent-free solutions for glaucoma surgeries. Their flagship product, MINT, offers a minimally invasive approach to restore aqueous outflow in patients with mild to moderate uncontrolled glaucoma. The company aims to enhance patient outcomes and improve the s... Read More